All Stories

  1. Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections

    Article • Frontiers in Cellular and Infection Microbiology, September 2020, Frontiers

    Carlos Pelleschi Taborda

  2. Intranasal Vaccine Using P10 Peptide Complexed within Chitosan Polymeric Nanoparticles as Experimental Therapy for Paracoccidioidomycosis in Murine Model

    Article • Journal of Fungi, September 2020, MDPI AG

    Carlos Pelleschi Taborda

  3. Advances in Fungal Peptide Vaccines

    Article • Journal of Fungi, July 2020, MDPI AG

    Carlos Pelleschi Taborda

  4. Pathogenicity Levels of Colombian Strains of Candida auris and Brazilian Strains of Candida haemulonii Species Complex in Both Murine and Galleria mellonella Experimental Models

    Article • Journal of Fungi, July 2020, MDPI AG

    Carlos Pelleschi Taborda

  5. Immunotherapy against Systemic Fungal Infections Based on Monoclonal Antibodies

    Article • Journal of Fungi, February 2020, MDPI AG

    Carlos Pelleschi Taborda

  6. A comment on “First report of tinea corporis caused by Arthroderma benhamiae in Brazil”

    Article • Brazilian Journal of Microbiology, January 2020, Springer Science + Business Media

    Carlos Pelleschi Taborda

  7. Comparison of carpet and toothbrush techniques for the detection of Microsporum canis in cats

    Article • Journal of Feline Medicine and Surgery, October 2019, SAGE Publications

    Aline Santana, Carlos Pelleschi Taborda

  8. Experimental Therapy of Paracoccidioidomycosis Using P10-Primed Monocyte-Derived Dendritic Cells Isolated From Infected Mice

    Article • Frontiers in Microbiology, July 2019, Frontiers

    Carlos Pelleschi Taborda

  9. Unravelling the nature of the spongy dark material in aged Turkevich gold nanoparticles colloidal solutions by CytoViva® dark-field imaging and HRTEM analysis

    Article • Micron, June 2019, Elsevier

    Carlos Pelleschi Taborda

  10. Vaccine Development to Systemic Mycoses by Thermally Dimorphic Fungi

    Article • Current Tropical Medicine Reports, May 2019, Springer Science + Business Media

    Carlos Pelleschi Taborda

  11. Molecular detection of Histoplasma capsulatum indoors: A public health approach

    Article • Revista Iberoamericana de Micología, April 2019, Elsevier

    Carlos Pelleschi Taborda

  12. Glucosylceramides From Lomentospora prolificans Induce a Differential Production of Cytokines and Increases the Microbicidal Activity of Macrophages

    Article • Frontiers in Microbiology, March 2019, Frontiers

    Carlos Pelleschi Taborda

  13. Paracoccidioides spp. and Histoplasma capsulatum: Current and New Perspectives

    Article • Current Topics in Medicinal Chemistry, November 2018, Bentham Science Publishers

    Prof Luiz R Travassos, Carlos Pelleschi Taborda, Gil Benard

  14. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment

    Article • Journal of Ethnopharmacology, April 2018, Elsevier

    Carlos Pelleschi Taborda

  15. Esporotricose - gato como fonte de infecção em foco epidêmico familiar em Guarulhos, São Paulo: relato de caso

    Article • Brazilian Journal of Veterinary Research and Animal Science, December 2017, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Carlos Pelleschi Taborda

  16. Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection

    Article • PLoS Neglected Tropical Diseases, September 2017, PLOS

    Carlos Pelleschi Taborda

  17. Editorial: Vaccines, Immunotherapy and New Antifungal Therapy against Fungi: Updates in the New Frontier

    Article • Frontiers in Microbiology, September 2017, Frontiers

    Carlos Pelleschi Taborda

  18. Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis

    Article • Frontiers in Microbiology, June 2017, Frontiers

    Carlos Pelleschi Taborda

  19. Antifungal Activity of the Biphosphinic Cyclopalladate C7a against Candida albicans Yeast Forms In Vitro and In Vivo

    Article • Frontiers in Microbiology, May 2017, Frontiers

    Cristina Spadari, Carlos Pelleschi Taborda

  20. Miltefosine is fungicidal to Paracoccidioides spp. yeast cells but subinhibitory concentrations induce melanisation

    Article • International Journal of Antimicrobial Agents, April 2017, Elsevier

    Cristina Spadari, Carlos Pelleschi Taborda

  21. Development of enzyme immunoassays (ELISA and Western blot) for the serological diagnosis of dermatophytosis in symptomatic and asymptomatic cats

    Article • Medical Mycology, March 2017, Oxford University Press (OUP)

    Carlos Pelleschi Taborda

  22. Linear Epitopes of Paracoccidioides brasiliensis and Other Fungal Agents of Human Systemic Mycoses As Vaccine Candidates

    Article • Frontiers in Immunology, March 2017, Frontiers

    Carlos Pelleschi Taborda

  23. Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi

    Article • Mediators of Inflammation, January 2017, Hindawi Publishing Corporation

    Carlos Pelleschi Taborda, Juliano Paccez

  24. Celebration of 60th anniversary of Brazilian Society for Microbiology

    Article • Brazilian Journal of Microbiology, December 2016, Springer Science + Business Media

    Carlos Pelleschi Taborda

  25. Peptidorhamnomannan negatively modulates the immune response in a scedosporiosis murine model

    Article • Medical Mycology, June 2016, Oxford University Press (OUP)

    Carlos Pelleschi Taborda

  26. Identification and Analysis of the Role of Superoxide Dismutases Isoforms in the Pathogenesis of Paracoccidioides spp.

    Article • PLoS Neglected Tropical Diseases, March 2016, PLOS

    Carlos Pelleschi Taborda

  27. Antibodies Against Glycolipids Enhance Antifungal Activity of Macrophages and Reduce Fungal Burden After Infection with Paracoccidioides brasiliensis

    Article • Frontiers in Microbiology, February 2016, Frontiers

    Carlos Pelleschi Taborda

  28. SENSIBILIDADE DO LAMINOCULTIVO DERMATOBAC® PARA O DIAGNÓSTICO DA ENDOMETRITE FÚNGICA EM ÉGUAS

    Article • Ciência Animal Brasileira, December 2015, FapUNIFESP (SciELO)

    Carlos Pelleschi Taborda

  29. Macrophage Interaction with Paracoccidioides brasiliensis Yeast Cells Modulates Fungal Metabolism and Generates a Response to Oxidative Stress

    Article • PLoS ONE, September 2015, PLOS

    Carlos Pelleschi Taborda

  30. PARACOCCIDIOIDOMYCOSIS: CHALLENGES IN THE DEVELOPMENT OF A VACCINE AGAINST AN ENDEMIC MYCOSIS IN THE AMERICAS

    Article • Revista do Instituto de Medicina Tropical de São Paulo, September 2015, FapUNIFESP (SciELO)

    Carlos Pelleschi Taborda

  31. 2-(2-Oxo-morpholin-3-yl)-acetamide Derivatives as Broad-Spectrum Antifungal Agents

    Article • Journal of Medicinal Chemistry, January 2015, American Chemical Society (ACS)

    Carlos Pelleschi Taborda

  32. Influence of melaleuca and copaiba oils onCandida albicansadhesion

    Article • Gerodontology, December 2014, Wiley

    Carlos Pelleschi Taborda

  33. Serological Diagnosis of Paracoccidioidomycosis: High Rate of Inter-laboratorial Variability among Medical Mycology Reference Centers

    Article • PLoS Neglected Tropical Diseases, September 2014, PLOS

    Carlos Pelleschi Taborda

  34. Monoclonal antibodies to heat shock protein 60 induce a protective immune response against experimental Paracoccidioides lutzii

    Article • Microbes and Infection, September 2014, Elsevier

    Carlos Pelleschi Taborda

  35. Immunization with P10 Peptide Increases Specific Immunity and Protects Immunosuppressed BALB/c Mice Infected with Virulent Yeasts of Paracoccidioides brasiliensis

    Article • Mycopathologia, August 2014, Springer Science + Business Media

    Carlos Pelleschi Taborda

  36. Radiochemical pharmacokinetic profile of P10 peptide with antifungal properties

    Article • Medical Mycology, June 2014, Oxford University Press (OUP)

    Carlos Pelleschi Taborda

  37. Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis

    Article • Fungal Genetics and Biology, November 2013, Elsevier

    Dr Arturo Casadevall, Carlos Pelleschi Taborda

  38. Erratum to: Isolation of Sporothrix schenckii From the Claws of Domestic Cats (Indoor and Outdoor) and in Captivity in São Paulo (Brazil)

    Article • Mycopathologia, August 2013, Springer Science + Business Media

    Carlos Pelleschi Taborda

  39. DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis induces long-term protection in presence of regulatory T cells

    Article • Microbes and Infection, March 2013, Elsevier

    Carlos Pelleschi Taborda

  40. Galleria mellonellaas a model host to studyParacoccidioides lutziiandHistoplasma capsulatum

    Article • Virulence, February 2013, Taylor & Francis

    Carlos Pelleschi Taborda

  41. Vaccines and immunotherapy against fungi: the new frontier

    Article • Frontiers in Microbiology, January 2013, Frontiers

    Carlos Pelleschi Taborda

  42. Paracoccidioidomycosis vaccine

    Article • Human Vaccines & Immunotherapeutics, October 2012, Taylor & Francis

    Carlos Pelleschi Taborda

  43. Therapeutic DNA Vaccine Encoding Peptide P10 against Experimental Paracoccidioidomycosis

    Article • PLoS Neglected Tropical Diseases, February 2012, PLOS

    Carlos Pelleschi Taborda

  44. New advances in the development of a vaccine against paracoccidioidomycosis

    Article • Frontiers in Microbiology, January 2012, Frontiers

    Carlos Pelleschi Taborda

  45. The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide

    Article • Frontiers in Microbiology, January 2012, Frontiers

    Carlos Pelleschi Taborda

  46. Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis

    Article • BMC Microbiology, January 2012, Springer Science + Business Media

    Carlos Pelleschi Taborda

  47. Prophylactic and Therapeutic Vaccination Using Dendritic Cells Primed with Peptide 10 Derived from the 43-Kilodalton Glycoprotein of Paracoccidioides brasiliensis

    Article • Clinical and Vaccine Immunology, November 2011, ASM Journals

    Carlos Pelleschi Taborda

  48. Isolation of Histoplasma capsulatum from bats in the urban area of São Paulo State, Brazil

    Article • Epidemiology and Infection, December 2010, Cambridge University Press

    Carlos Pelleschi Taborda

  49. Correlation of the in vitro antifungal drug susceptibility with the in vivo activity of fluconazole in a murine model of cerebral infection caused by Cryptococcus gattii

    Article • European Journal of Clinical Microbiology & Infectious Diseases, August 2010, Springer Science + Business Media

    Carlos Pelleschi Taborda

  50. Cutaneous mycoflora and CD4:CD8 ratio of cats infected with feline immunodeficiency virus

    Article • Journal of Feline Medicine and Surgery, April 2010, SAGE Publications

    Carlos Pelleschi Taborda

  51. Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis

    Article • British Journal of Pharmacology, February 2010, Wiley

    Carlos Pelleschi Taborda

  52. Identification and characterization of antigenic proteins potentially expressed during the infectious process of Paracoccidioides brasiliensis

    Article • Microbes and Infection, September 2009, Elsevier

    Carlos Pelleschi Taborda

  53. Paracoccidioides brasiliensis Vaccine Formulations Based on the gp43-Derived P10 Sequence and the Salmonella enterica FliC Flagellin

    Article • Infection and Immunity, February 2009, ASM Journals

    Carlos Pelleschi Taborda

  54. Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis

    Article • Microbes and Infection, October 2008, Elsevier

    Carlos Pelleschi Taborda

  55. In Vitro Activity of the Antifungal Plant Defensin RsAFP2 against Candida Isolates and Its In Vivo Efficacy in Prophylactic Murine Models of Candidiasis

    Article • Antimicrobial Agents and Chemotherapy, September 2008, ASM Journals

    Carlos Pelleschi Taborda

  56. Glycoconjugates and polysaccharides of fungal cell wall and activation of immune system

    Article • Brazilian Journal of Microbiology, June 2008, FapUNIFESP (SciELO)

    Carlos Pelleschi Taborda

  57. The Monoclonal Antibody against the Major Diagnostic Antigen of Paracoccidioides brasiliensis Mediates Immune Protection in Infected BALB/c Mice Challenged Intratracheally with the Fungus

    Article • Infection and Immunity, May 2008, ASM Journals

    Carlos Pelleschi Taborda

  58. Attempts at a peptide vaccine against paracoccidioidomycosis, adjuvant to chemotherapy

    Article • Mycopathologia, April 2008, Springer Science + Business Media

    Carlos Pelleschi Taborda

  59. Melanin as a virulence factor of Paracoccidioides brasiliensis and other dimorphic pathogenic fungi: a minireview

    Article • Mycopathologia, April 2008, Springer Science + Business Media

    Carlos Pelleschi Taborda

  60. Treatment options for paracoccidioidomycosis and new strategies investigated

    Article • Expert Review of Anti-infective Therapy, April 2008, Taylor & Francis

    Carlos Pelleschi Taborda

  61. Experimental paracoccidioidomycosis: alternative therapy with ajoene, compound fromAllium sativum, associated with sulfamethoxazole/trimethoprim

    Article • Medical Mycology, January 2008, Oxford University Press (OUP)

    Carlos Pelleschi Taborda

  62. Peptide Immunization as an Adjuvant to Chemotherapy in Mice Challenged Intratracheally with Virulent Yeast Cells of Paracoccidioides brasiliensis

    Article • Antimicrobial Agents and Chemotherapy, August 2006, ASM Journals

    Carlos Pelleschi Taborda

  63. Melanin in the dimorphic fungal pathogen Paracoccidioides brasiliensis: effects on phagocytosis, intracellular resistance and drug susceptibility

    Article • Microbes and Infection, January 2006, Elsevier

    Dr Arturo Casadevall, Carlos Pelleschi Taborda

  64. Synthesis and Immunological Activity of a Branched Peptide Carrying the T-cell Epitope of gp43, the Major Exocellular Antigen of Paracoccidioides brasiliensis

    Article • Scandinavian Journal of Immunology, January 2004, Wiley

    Carlos Pelleschi Taborda

  65. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirectC3-mediated interactions

    Article • European Journal of Immunology, July 2003, Wiley

    Dr Arturo Casadevall, Carlos Pelleschi Taborda

  66. Superoxide Dismutase Influences the Virulence of Cryptococcus neoformans by Affecting Growth within Macrophages

    Article • Infection and Immunity, January 2003, ASM Journals

    Carlos Pelleschi Taborda

  67. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) Are Involved in Complement-Independent Antibody-Mediated Phagocytosis of Cryptococcus neoformans

    Article • Immunity, June 2002, Elsevier

    Dr Arturo Casadevall, Carlos Pelleschi Taborda

  68. Immunoglobulin G Monoclonal Antibodies to Cryptococcus neoformans Protect Mice Deficient in Complement Component C3

    Article • Infection and Immunity, May 2002, ASM Journals

    Carlos Pelleschi Taborda

  69. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection

    Article • Journal of Clinical Investigation, December 2001, American Society for Clinical Investigation

    Dr Arturo Casadevall, Carlos Pelleschi Taborda